Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
Clinical trial NCT03370198 · TERMINATED
Trial details
- NCT number
- NCT03370198
- Sponsor
- Celyad Oncology SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2018-01-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.